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Summary
In the UK, there are policy and regulatory concerns regard-
ing the governance of care homes and healthcare provision
within these homes. From a public health perspective,
these issues can pose significant challenges to the provision
of safe and quality medication use services to care home
residents. The objective of this paper is to highlight an
important and neglected issue for the growing population
of institutionalized older adults. We reviewed relevant lit-
erature for the years 2000 to present and identified recent
efforts undertaken to improve medication safety standards
in UK care homes. We consider the limitations and reasons
for the National Health Service’s restricted role and lack of
leadership in providing medical services for this institutio-
nalized population. The efforts taken by the Department of
Health and other healthcare authorities targeting medica-
tion safety in care homes are also highlighted. In order to
improve the quality of healthcare, specifically in areas
related to medication safety and quality use of medicines,
interventions need to be taken by the national government
and similarly by local authorities and NHS commissioners.
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Introduction
The provision of high quality medication-related ser-
vices to UK care homes has been subject to increased
scrutiny over the past decade.1,2 In the UK, the
National Health Service (NHS) is the primary
national body responsible for the provision of health-
care, including medication-related services for care
homes. There were several changes to the administra-
tion of care homes in 2011 due to the widely reported
reallocation of resources and the requirement to deli-
ver to the UK government’s vision and mission.3
From a public health perspective, a compromise in
the safety and quality of medication use practices for
such a vulnerable population poses considerable
risks. Apart from causing harm to patients, the
NHS is faced with additional costs from increased
healthcare utilization. Adverse drug events in the eld-
erly that stem from medication errors and result in
hospitalization and emergency visits have a signiﬁ-
cant impact on healthcare resources, public health
and costs. For example, in 2000, the Medical
Protection Society and Medical Defence Union
reported that medication errors accounted for
around 25% of all litigation claims in UK general
practice.4 In particular, incorrect or inappropriate
dosage heads the list of errors.5
Older people, particularly those living in care
homes, often have multiple co-morbidities that
require them to have more prescriptions than their
younger counterparts. They are hence at a greater
risk of medication errors. Translating the evidence
base to practice in older people is a huge challenge.
One challenge relates to the complexities of govern-
ance pertaining to healthcare and medical services
provision in care homes.
Here, in this paper, we aim to provide an overview
of UK care home legislation and governance for the
beneﬁt of our international readers. We critically
review the governance structures of these homes.
We also analyse the reasons for the NHS’s limited
role and lack of leadership in providing medical ser-
vices for the care home population. We discuss recent
eﬀorts undertaken to address some of the challenges
and make recommendations to improve prescribing
practices and overall medication safety. Areas where
further work is needed are highlighted.
Methods
Relevant literature was identiﬁed through a search of
the online databases (MEDLINE, EMBASE and
Google Scholar) for the years 2000 to present using
keywords including the following: ‘care homes’,
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‘medication safety’, ‘safe prescribing’ and ‘govern-
ance’. A restriction was made for English language
articles only. Reference lists of all eligible articles
were checked for other relevant studies. Conference
proceedings were not searched. The sources were
cross-checked and this paper was produced from
those sources.
Complexity of governance
Care homes in England and Wales are governed by
the Care Standards Act 2000,6 in Scotland by the
Regulation of Care Act (Scotland) 20017 and in
Northern Ireland by the Health and Personal Social
Services Act (Northern Ireland) 2002.8 This legisla-
tion led to the introduction of the ‘national minimum
standards’ by the Department of Health, the Scottish
Executive and the Welsh Assembly. Regulations spe-
ciﬁc to each of the four constituent nations (England,
Scotland, Wales and Northern Ireland) of the UK
were also introduced to determine the responsibilities
of care home providers in maintaining and promoting
the health of their residents. Apart from setting out
requirements for activities such as record keeping, and
planning and monitoring health by care home staﬀ,
these regulations also set out healthcare requirements.
Although care home managers are ultimately respon-
sible for compliance with the healthcare requirements,
in practice, the provision of healthcare is largely
dependent on NHS healthcare professionals. Others
parties whose cooperation are required include local
authorities and private or voluntary organizations.
While there is mention of the NHS in the policies of
the four constituent nations of the UK, these policies
are largely focused on funding and regulatory issues
and do not outline speciﬁc requirements on the clin-
ical aspects of the NHS responsibilities for healthcare.
Because of this omission, the health departments have
been criticized for failing to clarify NHS obligations
or government expectations of its local NHS services
for care home residents.9
In addition, independent health and social care
regulatory bodies with the responsibility to monitor
the stipulated standards and regulations have been
set up in each nation. In England, the independent
regulator of health and adult social care, the Care
Quality Commission (CQC),10 was established by the
Health and Social Care Act 200811 and began operat-
ing inApril 2009. It replaced three earlier commissions:
the healthcare commission, the commission for social
care inspection and the mental health act commission.
The equivalent health and social care regulator in
Scotland is the Care Inspectorate (previously Social
Care and Social Work Improvement Scotland),12 in
Wales, the Care and Social Services Inspectorate
Wales13 and in Northern Ireland, the Regulation and
Quality Improvement Authority.14 These regulators
have a responsibility to regulate not only organizations
who provide care homes such as the British United
Provident Association15 but also providers and com-
missioners of NHS health services. Apart from the
health and social care regulations, care homes and
those working within them are subject to standards
set by the relevant agencies and professional bodies,
such as: (1) the requirements on healthcare profes-
sionals to meet professional standards by the General
Medical Council, the Nursing and Midwifery Council
and the General Pharmaceutical Council; and (2)
accreditation of quality standards by the
International Organization for Standardisation,
Health and Safety Acts and safeguarding conﬁdential-
ity of residents’ personal information as stipulated in
the Regulation and Data Protection Act 1998.15
Hence, there are many institutions and sectors that
are directly involved in the provisions and regulation
of healthcare for care home residents. In England, the
relevant establishments that are responsible for pro-
vision of medication-related services are: (1) the
CQC, which regulates services provided by the
NHS, local authorities, private companies or volun-
tary organizations; (2) NHS primary, community and
secondary care organizations that provide clinical
and medical services; (3) clinical commissioning
groups (formerly primary care trusts) that commis-
sion care; and (4) local authorities who manage,
monitor and improve local social services. Each
local authority has a social service department that
is responsible for care needs assessment primarily car-
ried out to establish what help and support is needed
by each resident.
Challenges in NHS healthcare provision
There are three key challenges. First, the framework of
a social care model within which healthcare for care
home residents is operating is now viewed as out-
dated.9 This is because care home residents’ priorities
are set primarily by social care and not healthcare. In
the past, residents often entered care homes as a result
of social factors, for example as a result of decisions
made by their relatives. However, nowadays the trend
has changed and residents are admitted, overwhelm-
ingly, as a consequence of illness-driven disability.16
The social care model is as such vital but insuﬃcient
tomeet residents’ healthneeds. Furthermore, fragmen-
tation in organization and service delivery between
health and social care (and also within the NHS) has
been identiﬁed as another impediment and has ham-
pered the development of a collaborativemodel of care
in which the NHS could deliver sustained support.9
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Second, there are clearly increasing health
demands for the ageing population. By 2035, 23%
of the population of UK is projected to be aged 65
years and over.17 In contrast, only 18% of the popu-
lation is expected to be below 16 years of age.17
Currently, in the UK, there are almost three times
as many beds in care homes as in NHS hospitals.18
Moreover, the needs of this vulnerable population are
speciﬁc and demanding as many residents suﬀer from
dementia and most are living with at least one dis-
ability (reportedly 40% and 75%, respectively18).
Third, with such an overwhelming increase in
needs, this could mean that the estimated half a mil-
lion older people19 residing in UK care homes could
have variable access to NHS services (such as prob-
lems obtaining local GP services, particularly in areas
where large or numerous care homes have increased
the number of residents). There is considerable vari-
ation in the quality of NHS provision, especially
around medication management, dementia and end-
of-life care.9 These variations have prompted the
CQC in England to conduct a special review for ﬁnd-
ing solutions to meet the healthcare needs and
demands of people living in care homes. The review
was conducted to determine whether or not people
living in care homes had equal access to NHS ser-
vices, had choice and control over their healthcare
and whether the delivered healthcare was safe and
respected their dignity.20 Aspects of locally enhanced
services reviewed included: (1) medication reviews; (2)
health assessments on admission; (3) specialist assess-
ments; (4) regular visits to home; (5) support with
end-of-life care plans; and (6) advising care home
staﬀ. Liaison with other healthcare professionals
was identiﬁed in the review’s preliminary ﬁndings as
one way to improve NHS healthcare services for
people living in care homes.
Medication safety concerns in care homes
Medication safety within the care homes is of concern
to the Department of Health. This concern was
reﬂected in the issuance of an alert in 2010 requesting
Primary Care Trusts to coordinate actions with their
primary medical care contractors, providers of
pharmaceutical services and social care to pursue
how medication errors in care homes can be
reduced.21 This directive was issued following the
completion of research commissioned by the
Department of Health’s Patient Safety Research
Programme entitled ‘The care homes use of medicines
study: prevalence, causes and potential harm of medi-
cation errors in care homes for older people’. The
authors found that 70% of residents had errors relat-
ing to medication prescribing, dispensing,
administration and/or monitoring. They further iden-
tiﬁed that unclear local leadership and lack of inter-
professional communication were key causes.2
Medication errors were deﬁned as prescribing,
monitoring, dispensing or administration errors.2 It
is of paramount importance that eﬀorts on improving
medication safety be targeted at reducing these
preventable errors.
Improving prescribing and
monitoring practices
Much evidence of published guidance on medication
use is pointing towards managing risk in medicines
management systems and processes, medicines man-
agement for long-term conditions and medicines
reconciliation.22 While safe dispensing and safe
administration are commonly focused on, aspects of
safe prescribing are, however, lacking considerably as
there is no evidence on which to base such guidance.
This is mainly because randomized controlled trials
involving older patients have often focused on mana-
ging a single disease state. When involving compli-
cated disease states, outcomes for older people have
been based on consensus and have often involved
extrapolating data derived from healthier patients.23
In reality, however, older people have numerous co-
morbidities for which they are prescribed multiple
medications and this must ideally be reﬂected in the
guidance on their treatment.23
One resource document was released in 1998 by
the National Prescribing Centre. The document ‘GP
prescribing support’24 was aimed at guiding PCTs
and health authorities to develop eﬀective prescribing
support. In reference to care homes, the document
suggested adopting the following measures: (1) set-
ting up manageable and eﬃcient systems for reorder-
ing of repeat prescriptions; (2) agreeing a list of
‘domestic remedies’ that the home keeps for the use
of its residents, avoiding repeat prescribing of, for
example, ‘as required’ simple analgesics; and (3)
appointing a GP as a speciﬁc point of contact
within the practice to deal with queries from nursing
and residential home staﬀ and who should also make
regular care home visits to maintain systems and
implement changes once they are agreed. In addition,
when reviewing care home prescribing, the guidance
advocated that particular attention be paid to over-
use of antipsychotics, sedatives and hypnotics, and
directions that indicated inappropriate timing of
drug administration, e.g. to consider timing to suit
the home’s schedule.24 Nevertheless, the guidance
did not propose any alternative for conducting a
more comprehensive medication review for care
home residents. Another government document that
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recognized the speciﬁc needs of the elderly with
regards to regular medication review was the
National Service Framework for Older People.25
Although it did not address the more complex pre-
scribing needs of care home residents, it did highlight
inherent issues that unpin the principles of care for
this group of older people.
Many have also agreed and supported the notion
that additional precautions are necessary when
prescribing to care home residents. These include
taking measures to optimize the repeat prescribing
system, for instance by having only one senior
nurse in each care home responsible for ordering
medication and notifying GPs of any amendments
to a prescription so that a new prescription could
be generated if necessary.2,24 Other precautions
include the regular monitoring of residents and ensur-
ing that essential laboratory tests are undertaken
periodically, side-eﬀects are detected and that therapy
is optimized. Eﬀective management of laboratory test
results is equally pivotal as some reports attributed
poor management for causing delays in receiving
laboratory test results. It was also of a concern to
GPs that the evidence base for medication monitor-
ing was not fully established for many drugs, par-
ticularly in terms of the frequency of monitoring;
even so, it has been deemed important to have
agreed policies for laboratory test monitoring of
drugs.26 Additionally, prescribing notes or ‘cautions’
in the drug monograph of the British National
Formulary are potentially useful, speciﬁcally with
regards to advice on special monitoring
requirements.26
Minimizing dispensing errors
In recent developments, concerted eﬀorts have been
initiated and will be led by the Royal Pharmaceutical
Society to minimize dispensing errors. This was trig-
gered by the debate in the House of Lords in
December 2011 of a tabled amendment to the
Health and Social Care Bill to address the issue of
healthcare professionals currently being at a risk of
prosecution when an inadvertent dispensing error
is made. This risk of prosecution, to which there is
currently no defence, is said to discourage reporting
of dispensing errors. The amendment was
withdrawn pending further consideration of the
issues. The Royal Pharmaceutical Society conse-
quently announced on its website on 12 January
2012 that it will work closely with the Department
of Health and the Medicines and Healthcare products
Regulatory Agency (MHRA) to take more stringent
measures to induce improvement and address the cur-
rent situation with regards to dispensing errors.27
Improving overall medication safety
in care homes
In terms of what has been done to address issues
pertaining to medication safety, the Department of
Health has reiterated the use of the Royal
Pharmaceutical Society’s guidance ‘The handling of
medicines in social care’ and the CQC standards
when making relevant commissioning decisions.
This provides best practice guidance based on current
legislation governing the handling of medicines in
the social care environment. It addresses handling
of controlled drug storage in care homes and ethical
issues to consider when residents refuse their
medicines.28
Another arm’s length executive body of the
Department of Health, the National Patient Safety
Agency (that ceased to exist from June 2012 and had
its key functions transferred to the NHS
Commissioning Board Special Health Authority29),
was involved in promoting good practice guidance
by, for example, outlining guidance in care home pro-
cedures for dealing with medication errors in an
attempt to reduce risks and improve safety in care
homes. Likewise, the MHRA, an executive agency of
the Department of Health responsible for the investi-
gation of harmful incidents as well as regulation of
medicines, medical devices and equipment used in
healthcare, has contributed to this facet of safety.
The MHRA has a section on its website designed spe-
ciﬁcally for care home staﬀ; the website includes guid-
ance, safety alerts and links to educational material to
assist staﬀ in the safe use and management of a wide
range of medicines and medical devices.30
In terms of who should take the lead on
initiating collaboration on medication safety, many
agencies and organizations have been proposed.
The white paper, ‘Pharmacy in England: building
on strengths – delivering the future’, in 2008 clearly
identiﬁed chief pharmacists as the most appropriate
professionals to take the lead on medication safety
matters.19
Conclusions
As the population ages, an increasing proportion of
older people are living in care homes. This shift in
demography has important implications for the
healthcare system as resources are pooled and dir-
ected towards meeting the needs of this vulnerable
older population. With an increasing demand for
care homes, there is a greater need to ensure that
the population living in these institutions is provided
with the best quality of care. The importance of
addressing the social issues and problems
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surrounding their prescriptions need to be acknowl-
edged. Necessary interventions need to be made by
the NHS and local authorities to improve the quality
of healthcare speciﬁcally in areas related to prescrib-
ing. While there are lessons that can be learned from
research ﬁndings and implementation of policy and
practice in other countries where there probably are
greater regulations of care home medication use
(countries such as the United States of America and
Australia), these cannot be easily compared or trans-
ferred to the UK as the baseline information such as
regulations, systems of care, databases and medicines
vary signiﬁcantly.
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